The addition of cycles of irinotecan/temozolomide (i/T) to cycles of vincristine, doxorubicin, cyclophosphamide (VDC) and cycles of ifosfamide, etoposide (IE) for the treatment of Ewing sarcoma (ES) Meeting Abstract


Authors: Meyers, P. A.; Ambati, S. R.; Slotkin, E. K.; Dela Cruz, F.; Wexler, L. H.
Abstract Title: The addition of cycles of irinotecan/temozolomide (i/T) to cycles of vincristine, doxorubicin, cyclophosphamide (VDC) and cycles of ifosfamide, etoposide (IE) for the treatment of Ewing sarcoma (ES)
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 558s
Language: English
ACCESSION: WOS:000442916003522
DOI: 10.1200/JCO.2018.36.15_suppl.10533
PROVIDER: wos
Notes: Meeting Abstract: 10533 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard H Wexler
    191 Wexler
  2. Srikanth Reddy Ambati
    31 Ambati
  3. Paul Meyers
    311 Meyers
  4. Emily Kanaya Slotkin
    65 Slotkin
Related MSK Work